The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment
Main Authors: | Belkıs Coskun, Oguzhan Dizdar, Seniz Korkmaz, Engin Ulukaya, Turkkan Evrensel |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2019-12-01
|
Series: | Contemporary Oncology |
Subjects: | |
Online Access: | https://www.termedia.pl/The-roles-of-M30-and-M65-in-the-assessment-of-treatment-response-and-prognosis-in-patients-with-non-small-cell-lung-cancer-who-receive-neoadjuvant-treatment,3,39554,1,1.html |
Similar Items
-
Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
by: Evrim Kahramanoğlu Aksoy, et al. -
Neoadjuvant Treatment in Pancreatic Cancer
by: Atsushi Oba, et al.
Published: (2020-02-01) -
Neoadjuvant Systemic Treatment of Primary Angiosarcoma
by: Kimberley M. Heinhuis, et al.
Published: (2020-08-01) -
History and current situation of neoadjuvant treatment for locally advanced esophageal cancer
by: Junyi Li, et al.
Published: (2021-09-01) -
Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)